Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

11.450
-0.400-3.38%
Volume:1.64M
Turnover:18.76M
Market Cap:29.40B
PE:21.20
High:11.800
Open:11.800
Low:11.210
Close:11.850
52wk High:14.081
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:0.67
T/O Rate:0.06%
Dividend:0.21
Dividend Rate:1.84%
EPS(LYR):0.540
ROE:18.77%
ROA:7.78%
PB:2.67
PE(LYR):21.20
PS:2.88

Loading ...

Simcere Pharmaceutical - Enters Exclusive Global Licensing Agreement with Roche for Sim0660 on Sept 1, 2026

THOMSON REUTERS
·
Sep 01

Simcere Pharmaceutical - Eligible for $75 Mln Upfront and up to $1.46 Bln in Milestone Payments

THOMSON REUTERS
·
Sep 01

Simcere Pharmaceutical - Eligible for Tiered Royalties of up to Double Digits on Future Net Sales

THOMSON REUTERS
·
Sep 01

Simcere Pharmaceutical Group (SEHK:2096) Stock Price Trails Margin Surge And DCF Gap

Simply Wall St.
·
Aug 21

Simcere Pharmaceutical Grants 795,000 RSUs Under 2021 Share Award Scheme

Reuters
·
Aug 21

Simcere Pharmaceutical Group's H1 Attributable Profit Rises 38%

MT Newswires Live
·
Aug 21

Simcere Pharmaceutical reshuffles joint company secretaries; wins three-year Listing Rules waiver

Bulletin Express
·
Aug 20

Simcere Pharma initiates up to RMB 1.00 billion share buyback, covering 10% of issued capital

Bulletin Express
·
Aug 20

Simcere Pharma's Half-Year Profit Jumps 48.7% on Adjusted Basis

Stock News
·
Aug 20

Simcere Pharma Appoints Zhu Da as Joint Company Secretary

Stock News
·
Aug 20

China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength

Reuters
·
Aug 20

Simcere Pharmaceutical Posts HY Net Income Attributable of RMB 829 MLN

Reuters
·
Aug 20

Simcere Pharmaceutical Files Board, Committee Member List with Disclosure Responsibilities

Reuters
·
Aug 20

Simcere Pharmaceutical Launches Open-Market Share Buyback of up to RMB 1 Billion

Reuters
·
Aug 20

Simcere Pharmaceutical - Share Repurchase Period from Aug 21, 2026 Until Next AGM or Earlier if Authority Revoked

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical - to Repurchase Shares in Open Market up to Rmb1,000 Mln

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical - DR. Zhou Will Serve as President

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical - Ren Jinsheng Will Serve as Chief Executive Officer

THOMSON REUTERS
·
Aug 20

Simcere Pharmaceutical Group H1 Revenue RMB 4,580 Million

THOMSON REUTERS
·
Aug 20

Simcere Pharma Surges Nearly 5% in Morning Trading as Huatai Retains Buy Rating

Deep News
·
Aug 20